Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
anticonvulsants
anticonvulsants, teratogenicity of
anticonvulsants, untoward effects of
carbamazepine
congenital malformation
dilantin
folic acid
folic acid antagonists
folic acid deficiency
malformation, CNS, congenital
neural tube defect
pregnancy, neurologic complications in
risk factors
trimethoprim-sulfamethoxazole
vitamin supplementation
vitamin, multiple
Showing articles 100 to 150 of 1518 << Previous Next >>

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Response of Anti-NMDA Receptor Encephalitis Without Tumor to Immunotherapy Including Rituximab
Neurol 71:1921-1923, Ishiura,H.,et al, 2008

Managing the Anticoagulated Patient with Atrial Fibrillation at High Risk of Stroke Who Needs Coronary Intervention
BMJ 337:1110-1111, Lip,G.Y.H., 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Anti-NMDA Receptor Encephalitis in Japan: Long-Term Outcome Without Tumor Removal
Neurol 70:504-511,500, Iizuka,T.,et al, 2008

Treatment-Responsive Subacute Limbic Encephalitis and NMDA Receptor Antibodies in a Man
Neurol 70:728-729, Novillo-Lopez,M.E.,et al, 2008

Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
Stroke 39:1482-1486,1406, Healey,J.S.,et al, 2008

The Writing on the Wall
Lancet 372:344, Wilder-Smith,E.P. &Ng,E.S., 2008

Clinicopath Conf., Anti-MNDAR Antibody Mediated Paraneoplastic Limbic Encephalitis Associated With Ovarian Teratoma
NEJM 359:842-853, Case 26-2008, 2008

Neuro-Ophthalmologic Manifestations of Paraneoplastic Syndromes
J Neuro-Ophthalmol 28:58-68, Ko,M.W.,et al, 2008

Combining Aspirin With Oral Anticoagulant Therapy: Is This a Safe and Effective Practice in Patients With Atrial Fibrillation?
Stroke 38:1652-1654, Gorelick,P.B., 2007

Efficacy of Folic Acid Supplementation in Stroke Prevention: A Meta-Analysis
Lancet 369:1876-1882,1841, Wang,X.,et al, 2007

Reduction in Neural-Tube Defects After Folic Acid Fortification in Canada
NEJM 357:135-142, De Wals,P.,et al, 2007

Warfarin Versus Aspirin for Stroke Prevention in an Elderly Community Population With Atrial Fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A Randomised Controlled Trial
Lancet 370:493-503,460, Mant,J.,et al, 2007

Antithrombotic and Interventional Treatment Options in Cardioembolic Transient Ischaemic Attack and Ischaemic Stroke
JNNP 78:14-24, McCabe,D.J.H. &Rakhit,R.D., 2007

Warfarin vs Aspirin for Symptomatic Intracranial Stenosis: Subgroup Analyses from WASID
Neurol 67:1275-1278, Kasner,S.E.,et al, 2006

A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease
Arch Neurol 63:49-54, Reisberg,B.,et al, 2006

Immediate Angicoagulation for Acute Stroke in Atrial Fibrillation: No
Stroke 37:3054-3055,3056, Sandercock,P., 2006

Use of Single and Combined Antithrombotic Therapy and Risk of Serious Upper Gastrointestinal Bleeding: Population Based Case-Control Study
BMJ 333:726-728, Hallas,J.,et al, 2006

Management of Antiphospholipid Antibody Syndrome, A Systematic Review
JAMA 295:1050-1057, Lim,W.,et al, 2006

Clopidogrel Plus Aspirin Versus Oral Anticoagulation for Atrial Fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE W): A Randomised Controlled Trial
Lancet 367:1903-1912,1877, The ACTIVE Writing Group on behalf of the ACTIVE Investigators, 2006

Homocysteine and Stroke: Evidence on a Causal Link From Mendelian Randomisation
Lancet 365:224-232, 194, Casas, J.P., et al, 2005

Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients with Nonrheumatic ATrial Fibrillation and a History of Stroke or Transient Ischemic Attack
Stroke 36:914-915, Saxena,R. &Koudstaal,P.J., 2005

Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis
NEJM 352:1305-1316, 1368, Chimowitz,M.I.,et al, 2005

Autoantibodies to Folate Receptors in the Cerebral Folate Deficiency Syndrome
NEJM 352:1985-1991, Ramaekers,V.T.,et al, 2005

Seizures Following Reduction in Phenytoin Level After Orally Administered Folic Acid
Neurol 64:1982, Steinweg,D.L.&Bentley,M.L., 2005

Folate, Vitamin B12, and Risk of Ischemic and Hemorrhagic Stroke
Stroke 36:1426-1431, Guelpen,B.V.,et al, 2005

Extracranial Arterial Dissection, Angicoagulation Is the Treatment of Choice: Against
Stroke 36:2042-2043,2043, Lyrer,P.A., 2005

Survival after Treatment of Rabies with Induction of Coma
NEJM 352:2508-2514,2549, Willoughby,Jr.,R.E.,et al, 2005

Intracerebral Hemorrhage
The Neurologist 11:311-324, Badjatia,N. &Rosand,J., 2005

Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004

Combined Anticoagulant-Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients
Stroke 35:2362-2367, Shireman,T.I.,et al, 2004

Prescription of Antithrombotic Therapy in Older Patients Hospitalized for Transient Ischemic Attack and Ischemic Stroke:The GIFA Study
Stroke 35:913-917, Volpato,S.,et al, 2004

Folate Intake and Risk of Stroke Among Women
Stroke 35:1259-1263, Al-Delaimy,W.K.,et al, 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004

Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil, A Randomized Controlled Trial
JAMA 291:317-324, Tariot,P.N.,et al, 2004

Antithrombotic Drugs for Carotid Artery Dissection
Stroke 25:613-614, Lyrer,P.&Engelter,S., 2004

Hyperhomocysteinemia as an Independent Risk Factor for Silent Brain Infarction
Neurol 61:1595-1599, Kim,N.K.,et al, 2003

Continuation of Medically Necessary Aspirin and Warfarin During Cutaneous Surgery
Mayo Clin Proc 78:1392-1396, Otley,C.C., 2003

Memantine in Moderate-to-Severe Alzheimer's Disease
NEJM 348:1333-1341, Reisberg,B.,et al, 2003

Pernicious Anemia with Neuropsychiatric Dysfunction in a Patient with Sickle Cell Anemia Treated with Folate Supplementation
NEJM 348:2204-2207, Dhar,M.,et al, 2003

Major Malformations in Offspring of Women with Epilepsy
Neurol 60:575-579, Kaaja,E.,et al, 2003

Risks and Benefits of Anticoagulant and Antiplatelet Medication Use Before Cataract Surgery
Ophthalmology 110:1784-1788, Katz,J.,et al, 2003

Tolerability of Memantine in Combination with Cholinesterase Inhibitors in Dementia Therapy
Int Clin Psychopharm 18:81-85, Hartmann,S.& Mobius, H.J., 2003

Symptoms of B12 Deficiency Can Occur in Women of Child Bearing Age Supplemented with Folate
Neurol 58:1572-1573, Drazkowski,J.,et al, 2002

Dietary Intake of Folate and Risk of Stroke in US Men and Women
Stroke 33:1183-1189, Bazzano,L.A.,et al, 2002

New Evidence for Stroke Prevention
JAMA 288:1388-1395, Straus,S.E.,et al, 2002

Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients
Stroke 33:2664-2669, Scott,P.A.,et al, 2002

Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy
Stroke 33;2722-2727, Hart,R.G.,et al, 2002



Showing articles 100 to 150 of 1518 << Previous Next >>